Abstract
Highly Active Antiretroviral Therapy (HAART) has significantly contributed to the increase of HIV-infected survivors over 50 years of age. Unfortunately, patients are required to stay on long-term HAART, which may be causally related to the development of neurological problems such as chronic pain. Little is known about the contribution of HAART or its therapeutic agents to the pathogenesis of pain during aging. In this study, we determined the effect of nucleoside reverse transcriptase inhibitors (NRTIs) on the development of mechanical allodynia and the potential underlying mechanism in aging mice (15.5 months). We found that systemic administration of individual NRTIs, including ddC (2′-3′-dideoxycytidine), ddI (didanosine), AZT (3′-azido-3′-deoxythymidine) and d4T (2′, 3′-didehydro-2′, 3′-dideoxythymidine), induced allodynia in similar magnitudes and temporal profiles. We used ddC as a representative to investigate cellular and molecular processes induced by NRTIs in the spinal cord that probably underlie the development of allodynia. The results showed that ddC caused evident neuroinflammation in the spinal cord, suggested by the up-regulation of proinflammatory cytokines TNF-α and IL-1β and the reactions of microglia and astrocytes. In addition, we found that Wnt5a, a critical regulator of neuroinflammation, was also up-regulated. Pharmacological inhibition of Wnt5a blocked ddC-induced up-regulation of TNF-α and astrocyte reaction, while activation of Wnt5a signaling potentiated these processes. Furthermore, our data showed that inhibition of Wnt5a significantly reversed ddC-induced mechanical allodynia in aging mice. The results collectively suggest that NRTIs may contribute to the development of chronic pain in aging patients by inducing Wnt5a-regulated neuroinflammation.
Similar content being viewed by others
References
Brew B, Crowe S, Landay A, Cysique L, Guillemin G (2009a) Neurodegeneration and ageing in the HAART era. J NeuroImmune Pharmacol 4:163
Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009b) Neurodegeneration and ageing in the HAART era. J NeuroImmune Pharmacol 4:163–174
Cao DL, Zhang ZJ, Xie RG, Jiang BC, Ji RR, Gao YJ (2014) Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol 261:328–336
Chiu IM, Heesters BA, Ghasemlou N, Von Hehn CA, Zhao F, Tran J, Wainger B, Strominger A, Muralidharan S, Horswill AR, Bubeck Wardenburg J, Hwang SW, Carroll MC, Woolf CJ (2013) Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501:52–57
Eisfeld C, Reichelt D, Evers S, Husstedt I (2013) CSF penetration by antiretroviral drugs. CNS Drugs 27:31–55
Grovit-Ferbas K, Harris-White ME (2010) Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol Res 48:40–58
Hao S (2013) The molecular and pharmacological mechanisms of HIV-related neuropathic pain. Curr Neuropharmacol 11:499–512
Hewitt DJ, McDonald M, Portenoy RK, Rosenfeld B, Passik S, Breitbart W (1997) Pain syndromes and etiologies in ambulatory AIDS patients. Pain 70:117–123
Iida T, Yi H, Liu S, Huang W, Kanda H, Lubarsky DA, Hao S (2016) Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats. Exp Neurol 281:17–27
Jenei V, Sherwood V, Howlin J, Linnskog R, Safholm A, Axelsson L, Andersson T (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A 106:19473–19478
Kalayjian RC, Al-harthi L (2009) The effects of aging and HIV disease. In: Paul RH, Sacktor NC, Valcour V, Tashima KT (eds) HIV and the brain. Humana Press, New York, pp 331–346
Li B, Shi Y, Shu J, Gao J, Wu P, Tang SJ (2013) Wingless-type mammary tumor virus integration site family, member 5A (Wnt5a) regulates human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein 120 (gp120)-induced expression of pro-inflammatory cytokines via the Ca2+/calmodulin-dependent protein kinase II (CaMKII) and c-Jun N-terminal kinase (JNK) signaling pathways. J Biol Chem 288:13610–13619
Margolis AM, Heverling H, Pham PA, Stolbach A (2014) A review of the toxicity of HIV medications. J Med Toxicol 10:26–39
Munawar N, Oriowo MA, Masocha W (2017) Antihyperalgesic activities of endocannabinoids in a mouse model of antiretroviral-induced neuropathic pain. Front Pharmacol 8:136
Myers JD (2009) Growing old with HIV: the AIDS epidemic and an aging population. JAAPA 22:20–24
Patel D, Crane LR (2011) Growing old with HIV. Curr Infect Dis Rep 13:75–82
Safholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T (2006) A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem 281:2740–2749
Valcour V, Sithinamsuwan P, Letendre S, Ances B (2011) Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 8:54–61
Weber J, Mitchell D, Kamerman PR (2007) Oral administration of stavudine induces hyperalgesia without affecting activity in rats. Physiol Behav 92:807–813
Wu T, Zhang J, Geng M, Tang SJ, Zhang W, Shu J (2017) Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling. Sci Rep 7:4117
Yuan S, Shi Y, Tang SJ (2012) Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain. J NeuroImmune Pharmacol 7:904–913
Yuan SB, Shi Y, Chen J, Zhou X, Li G, Gelman BB, Lisinicchia JG, Carlton SM, Ferguson MR, Tan A, Sarna SK, Tang SJ (2014) Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. Ann Neurol 75:837–850
Yuan SB, Ji G, Li B, Andersson T, Neugebauer V, Tang SJ (2015) A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain. Pain 156:1311–1319
Zheng X, Ouyang H, Liu S, Mata M, Fink DJ, Hao S (2011) TNFalpha is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats. Brain Behav Immun 25:1668–1676
Zheng W, Huang W, Liu S, Levitt RC, Candiotti KA, Lubarsky DA, Hao S (2014) IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats. Mol Pain 10:49
Acknowledgements
This work was supported by NIH grants to SJT: R01NS079166, R01DA036165 and R01NS095747.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All animal procedures were performed in accordance with the ethical standards of the University of Texas Medical Branch, Galveston, Texas, USA
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Yuan, S., Shi, Y., Guo, K. et al. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Induce Pathological Pain through Wnt5a-Mediated Neuroinflammation in Aging Mice. J Neuroimmune Pharmacol 13, 230–236 (2018). https://doi.org/10.1007/s11481-018-9777-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-018-9777-6